Acurx Pharmaceuticals, Inc.ACXPNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank91
Year-over-Year Change
Year-over-year earnings per share growth rate
Percentile
P91
Near historical high
vs 2Y Ago
2.4x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 34.92% |
| Q2 2025 | 11.68% |
| Q1 2025 | 34.56% |
| Q4 2024 | 5.22% |
| Q3 2024 | 33.78% |
| Q2 2024 | 7.95% |
| Q1 2024 | 25.53% |
| Q4 2023 | -58.66% |
| Q3 2023 | 14.46% |
| Q2 2023 | -12.00% |
| Q1 2023 | -238.89% |
| Q4 2022 | 156.25% |
| Q3 2022 | -23.08% |
| Q2 2022 | 0.00% |
| Q1 2022 | 0.00% |
| Q4 2021 | 43.48% |
| Q3 2021 | 19.30% |
| Q2 2021 | -280.00% |
| Q1 2021 | -36.36% |
| Q4 2020 | 21.43% |
| Q3 2020 | -46.29% |
| Q2 2020 | 26.38% |
| Q1 2020 | 0.00% |